SBIR/STTR Research Award
Accelerate Adoption of Galaxy Pro in the Biomedical Research Marketplace
Award amount
$280,000Program and phase
STTR · Phase IAward year
2019Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- GalaxyWorks LLC
- Proposal award date
- 2019-09-13
- Contract end date
- 2020-06-30
- UEI
- MFA8BXME5917
- Solicitation number
- PA19-029
- Topic code
- NHGRI
Research abstract
Project Summary
Galactic Core LLC aims to develop a robust, scalable, and managed service for performing enterprise-grade
biomedical data analysis. The service will be based on the popular open-source Galaxy application
(https://galaxyproject.org/), offering unlimited data storage and compute capabilities with an extremely
powerful, flexible, and collaborative environment for analyzing data. The service will be run as a set of private
environments with dedicated computers being setup and managed for individuals, research groups, or
institutions. Data generation assays and analysis tools in the Biomedical Sciences continue to evolve rapidly
and fixed 1-click approach to data analysis is very challenging as the analysis must be quickly adapted to new
methods and types of data. This landscape requires a proportionally vast and growing amount of capacity for
data analysis that can be readily tailored to the domain and integrates with an array of external resources.
Galaxy with its accessible web-interface and a worldwide community is uniquely positioned to adapt to this
changing landscape as it provides access to andgt;6,500 best-of-breed analysis tools and andgt;100 data types. These
numbers are unmatched by any similar solution, yet the rate at which tools and data types are added continues
to increase. However, the challenges with setting up, maintaining, and evolving the necessary data analysis
environment present an obstacle for biomedical data analysis, particularly for small firms and laboratories. The
goal of our STTR Phase I project is to streamline the process of setting up and managing a production-quality
instance of Galaxy and deliver it as a scalable, managed, always-on service. As part of this I-Corps program,
we will identify customer pains and gains to better stear product development. Our goal for this program is to
gain training and experience with customer discovery and business management as we develop this
product-market fit. Broad and simple availability of a powerful biomedical data analysis platform would
fundamentally improve access to biomedical data analysis capacity and facilitate routine analyses by research
labs and institutions, small businesses, as well as mid-sized corporations.Project Narrative
The popular Galaxy application (https://galaxyproject.org/) is uniquely positioned to address the continuously
evolving biomedical data analysis needs because it integrates and provides ready-access to thousands of
best-of-breed analysis tools and data types. Galactic Core LLC has set out to offer Galaxy as a fully managed
software service that will take data analysis for basic research, precision medicine, and translational medicine
mainstream. Participation in the I-Corps program will help identify product-market fit as we develop the
product.
Technology keywords
Not reported
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- Platform to support clinical variant interpretation through probabilistic assessment of functional evidence
- Innovations to expand and accelerate the commercial impact of DNA modifications
- High-throughput Direct Sequencing and Quantitative Mapping of RNA Modifications using Mass Spectrometry.
- Super-resolution single-molecule sequencing by observing the dynamic hybridization of a repertoire of oligonucleotides to DNA targets
- Exhaustive de novo sequencing of every RNA in a sample by a layer-by-layer mass spectrometry ladder intensity approach.